AUTOIMMUNE HEPATITIS
Clinical trials for AUTOIMMUNE HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEPATITIS trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for autoimmune hepatitis patients who fail standard treatment
Disease control CompletedThis study tested a new biologic drug called VAY736 in 68 adults with autoimmune hepatitis who did not get better with or could not tolerate standard treatments. The goal was to see if VAY736 could safely help normalize liver enzyme levels. Participants received either VAY736 or …
Matched conditions: AUTOIMMUNE HEPATITIS
Phase: PHASE2, PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug shows promise for liver disease in early trial
Disease control CompletedThis study tested a new drug called zetomipzomib in 24 adults with autoimmune hepatitis, a condition where the immune system attacks the liver. Participants received either the drug or a placebo along with their usual treatment for 24 weeks, with an option to continue the drug fo…
Matched conditions: AUTOIMMUNE HEPATITIS
Phase: PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New MRI scan could replace liver biopsies
Diagnosis CompletedThis study tested how well a special MRI scan called LiverMultiScan can measure liver fat, iron, and scarring. 61 adults with various liver diseases had up to 6 scans on different machines. The goal was to see if the results are consistent when repeated on the same scanner or on …
Matched conditions: AUTOIMMUNE HEPATITIS
Sponsor: Perspectum • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC